- Interventional cardiology and peripheral vascular devices are critical tools used in the diagnosis and treatment of cardiovascular and peripheral artery diseases through minimally invasive procedures such as angioplasty, stenting, and atherectomy
- The demand for these devices is significantly driven by the increasing prevalence of cardiovascular diseases, rising geriatric population, and growing preference for minimally invasive procedures over traditional surgery
- North America is expected to dominate the interventional cardiology and peripheral vascular devices market with largest market share of 36.6%, due to its advanced healthcare infrastructure, strong presence of key market players, and high adoption of innovative cardiovascular technologies
- Asia-Pacific is expected to be the fastest growing region in the interventional cardiology and peripheral vascular devices market during the forecast period due to rising healthcare investments, increasing awareness of cardiovascular health, and improving access to modern treatment options
- Coronary stents segment is expected to dominate the market with a largest market share of 64.7% due to widespread use in coronary and peripheral interventions, along with continuous innovations such as drug-eluting and bioresorbable stents enhancing procedural success and patient outcomes
